2nd Wnt And B-Catenin Pathway Targeted Drug Development Summit
After 2 decades of research, it is now the time for drug developers to act and get together at the 2nd Wnt/B-Catenin Pathway Targeted Drug Development Summit. As the one and only industry-led meeting, you will be equipped with unparalleled insights in:
- Wnt/B-Catenin's structural biology and medicinal chemistry - turning the undruggable druggable
- Comparison of different Wnt/B-Catenin modulation approaches, its interaction with TIL and tumor microenvironment for targeted, combination therapies
- Translating basic science into clinical design - from scheduling to dosing, overcoming toxicity to widen the therapeutic window with safety in mind
- Validating a clinical biomarker for patient selection
In collaboration with Wnt/B-Catenin pioneers such as Iterion Therapeutics, Leap Therapeutics, FogPharma, this is your unique opportunity to join and meet 60+ drug developers to forge long-term collaboration and advance Wnt/B-Catenin as a valuable target and clinical asset, propelling to provide first-in-class treatments for patients!
Academic Admission: USD 2599.00,
Drug Developer: USD 2999.00,
Service Provider: USD 3599.00
Hanson Wade specialises in bringing people together through outstanding business conferences and year round community contact.
Comments on 2nd Wnt And B-Catenin Pathway Targeted Drug Development Summit
Peoples Interested in Visit
Boston 02128, Massachusetts, United States